Literature DB >> 24946077

Failure of perivascular drainage of β-amyloid in cerebral amyloid angiopathy.

Cheryl A Hawkes1, Nimeshi Jayakody, David A Johnston, Ingo Bechmann, Roxana O Carare.   

Abstract

In Alzheimer's disease, amyloid-β (Aβ) accumulates as insoluble plaques in the brain and deposits in blood vessel walls as cerebral amyloid angiopathy (CAA). The severity of CAA correlates with the degree of cognitive decline in dementia. The distribution of Aβ in the walls of capillaries and arteries in CAA suggests that Aβ is deposited in the perivascular pathways by which interstitial fluid drains from the brain. Soluble Aβ from the extracellular spaces of gray matter enters the basement membranes of capillaries and drains along the arterial basement membranes that surround smooth muscle cells toward the leptomeningeal arteries. The motive force for perivascular drainage is derived from arterial pulsations combined with the valve effect of proteins present in the arterial basement membranes. Physical and biochemical changes associated with arteriosclerosis, aging and possession of apolipoprotein E4 genotype lead to a failure of perivascular drainage of soluble proteins, including Aβ. Perivascular cells associated with arteries and the lymphocytes recruited in the perivenous spaces contribute to the clearance of Aβ. The failure of perivascular clearance of Aβ may be a major factor in the accumulation of Aβ in CAA and may have significant implications for the design of therapeutics for the treatment of Alzheimer's disease.
© 2014 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.

Entities:  

Keywords:  Alzheimer's disease; amyloid β; cerebral amyloid angiopathy; interstitial fluid neuroimmunology; perivascular drainage

Mesh:

Substances:

Year:  2014        PMID: 24946077     DOI: 10.1111/bpa.12159

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  64 in total

Review 1.  Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.

Authors:  Shu-Hui Xin; Lin Tan; Xipeng Cao; Jin-Tai Yu; Lan Tan
Journal:  Neurotox Res       Date:  2018-04-07       Impact factor: 3.911

2.  Impaired Peripheral Lymphatic Function and Cerebrospinal Fluid Outflow in a Mouse Model of Alzheimer's Disease.

Authors:  Sunkuk Kwon; Ines Moreno-Gonzalez; Kathleen Taylor-Presse; George Edwards Iii; Nazaret Gamez; Olivia Calderon; Banghe Zhu; Fred Christian Velasquez; Claudio Soto; Eva M Sevick-Muraca
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

3.  Pathological changes in basement membranes and dermal connective tissue of skin from patients with hereditary cystatin C amyloid angiopathy.

Authors:  Asbjorg Osk Snorradottir; Helgi J Isaksson; Saevar Ingthorsson; Elias Olafsson; Astridur Palsdottir; Birkir Thor Bragason
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

4.  Changes in intracranial venous blood flow and pulsatility in Alzheimer's disease: A 4D flow MRI study.

Authors:  Leonardo A Rivera-Rivera; Tilman Schubert; Patrick Turski; Kevin M Johnson; Sara E Berman; Howard A Rowley; Cynthia M Carlsson; Sterling C Johnson; Oliver Wieben
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 5.  Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?

Authors:  Antoine Louveau; Sandro Da Mesquita; Jonathan Kipnis
Journal:  Neuron       Date:  2016-09-07       Impact factor: 17.173

Review 6.  Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.

Authors:  Milos D Ikonomovic; Zhiping Mi; Eric E Abrahamson
Journal:  Ageing Res Rev       Date:  2016-11-06       Impact factor: 10.895

7.  Contact sport participation and chronic traumatic encephalopathy are associated with altered severity and distribution of cerebral amyloid angiopathy.

Authors:  Oliver J Standring; Jacob Friedberg; Yorghos Tripodis; Alicia S Chua; Jonathan D Cherry; Victor E Alvarez; Bertrand R Huber; Weiming Xia; Jesse Mez; Michael L Alosco; Raymond Nicks; Ian Mahar; Morgan J Pothast; Hannah M Gardner; Gaoyuan Meng; Joseph N Palmisano; Brett M Martin; Brigid Dwyer; Neil W Kowall; Robert C Cantu; Lee E Goldstein; Douglas I Katz; Robert A Stern; Ann C McKee; Thor D Stein
Journal:  Acta Neuropathol       Date:  2019-06-10       Impact factor: 17.088

8.  Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity.

Authors:  Sara E Berman; Lindsay R Clark; Leonardo A Rivera-Rivera; Derek Norton; Annie M Racine; Howard A Rowley; Barbara B Bendlin; Kaj Blennow; Henrik Zetterberg; Cynthia M Carlsson; Sanjay Asthana; Patrick Turski; Oliver Wieben; Sterling C Johnson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 9.  Understanding the role of the perivascular space in cerebral small vessel disease.

Authors:  Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

Review 10.  Imaging the Perivascular Space as a Potential Biomarker of Neurovascular and Neurodegenerative Diseases.

Authors:  Joel Ramirez; Courtney Berezuk; Alicia A McNeely; Fuqiang Gao; JoAnne McLaurin; Sandra E Black
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.